The Medicines Company Appoints John C. Kelly to Board of Directors
The Medicines Company (NASDAQ: MDCO (/news_room/Stock?ticker=MDCO)) today announced the appointment of John C. Kelly to the Company’s Board of Directors and Audit Committee of the Board. Mr. Kelly has more than 40 years of experience in accounting and finance, as well as a background in healthcare. He recently retired after serving as Vice President and Controller of Wyeth. Mr. Kelly also serves on the Boards of C.R. Bard and Horizon Blue Cross Blue Shield of New Jersey.Mr. Kelly stated, “The Medicines Company’s expert focus on acute and intensive care in hospitals is particularly exciting. Throughout my experience, I have… View full post on Live News from PR-USA.net
Recent Blog Posts:
Popular Blog Posts:
Subscribe to our RSS